Welcome to our dedicated page for Camden Natl SEC filings (Ticker: CAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
This page provides access to U.S. Securities and Exchange Commission filings for Camden National Corporation (NASDAQ: CAC), a Maine‑incorporated bank holding company. Through these filings, investors can review the company’s official disclosures about its commercial banking and wealth management activities, financial performance, capital position, and corporate governance.
Camden National Corporation files a range of documents with the SEC, including Form 8‑K current reports that announce material events. Recent 8‑K filings referenced in the available information cover topics such as quarterly earnings releases, dividend declarations, investor presentations, and board succession changes. These filings often include or reference press releases that detail net income, loan and deposit levels, asset quality metrics, and capital ratios, as well as information about quarterly cash dividends on the company’s common stock.
In addition to current reports, investors can use this filings page to locate the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which provide more extensive discussions of Camden National Corporation’s business model, risk factors, regulatory environment, and financial statements. For a bank holding company, these periodic reports are key sources for understanding loan portfolios, deposit funding, capital adequacy, and non‑interest income streams, alongside the risk and capital disclosures that accompany them.
Users can also review filings related to dividend actions and board changes, as reflected in 8‑K items on dividend declarations and director retirement and succession. Where applicable, insider transaction reports on Form 4 can be consulted to see equity transactions by directors and officers.
Stock Titan’s platform enhances these regulatory documents with AI‑powered summaries that highlight the main points of lengthy filings, helping readers quickly identify key financial and governance information. Real‑time updates from the SEC’s EDGAR system, combined with simplified explanations of complex forms such as 10‑K, 10‑Q, 8‑K, and Form 4, make it easier to follow Camden National Corporation’s regulatory reporting and its implications for the CAC stock.
Camden National Corp EVP Garrett McKnight reported routine tax-related share withholdings tied to vesting equity awards. On April 29 and April 30, 2026, a total of 241 shares of common stock were withheld to satisfy minimum tax obligations on restricted shares that vested on those dates.
After these transactions, McKnight directly held 6,268 shares of common stock. This holding includes 4,398 restricted stock units and restricted shares that remain subject to vesting and forfeiture restrictions. The Form 4 indicates tax-withholding dispositions rather than open-market sales.
Smith Ryan A reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP Ryan A. Smith received an equity grant of 1,281 shares of Common Stock. The award was made as restricted stock under the company’s 2022 Equity and Incentive Plan and amendment at a value of $50.67 per share.
The restricted stock awards are scheduled to vest pro-rata over the next three years, contingent on his continued employment through each vesting date. Each restricted stock award represents the right to receive one share of common stock upon vesting. Following this grant, Smith directly holds 24,276 shares of Camden National common stock, which include 7,711 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Camden National Corp CEO Simon Griffiths received an equity grant of 6,919 shares of Common Stock, awarded as restricted stock under the company’s 2022 Equity and Incentive Plan and its amendment. The award is priced at $50.67 per share for reporting purposes.
The restricted stock is scheduled to vest pro rata over the next three years, subject to Griffiths’ continued employment through each vesting date. Each restricted stock award converts into one share of common stock at vesting. After this grant, he directly holds 44,399 shares, including 31,098 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Camden National Corp EVP William H. Martel received an award of 1,281 shares of common stock, granted as restricted stock under the company’s 2022 Equity and Incentive Plan and its amendment. The award is scheduled to vest pro-rata over the next three years, conditioned on continued employment through each vesting date.
Each restricted stock award converts into one share of common stock upon vesting. After this grant, Martel directly holds 22,198 shares of Camden National common stock, including 8,380 restricted stock units and restricted shares that remain subject to vesting and forfeiture provisions.
Forbes Andrew reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp executive Andrew Forbes received a compensation-related equity grant rather than buying shares on the market. On this Form 4, the EVP was granted 1,036 shares of common stock as restricted stock awards at a reference price of $50.67 per share.
The awards were granted under the company’s 2022 Equity and Incentive Plan and are scheduled to vest pro-rata over the next three years, subject to continued employment through each vesting date. After this grant, Forbes directly holds 6,147 common shares, including 4,815 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Rose Patricia A reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp EVP Patricia A. Rose received a grant of 1,281 shares of common stock valued at $50.67 per share. The award is in the form of restricted stock under the company’s 2022 Equity and Incentive Plan and its amendment.
The restricted shares are scheduled to vest pro-rata over the next three years, conditioned on continued employment through each vesting date. After this grant, Rose directly holds a total of 28,923.593 common shares, including 5,098 restricted stock units and restricted shares that remain subject to vesting and forfeiture terms.
Camden National Corp EVP David Ackley received a grant of 1,087 shares of common stock as a restricted stock award. The grant was made at $50.67 per share under the company’s 2022 Equity and Incentive Plan and is scheduled to vest pro-rata over the next three years, subject to continued employment.
Each restricted stock award converts into one share of common stock at vesting. After this award, Ackley directly holds 13,634.958 shares of common stock, which include 6,222 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Archer Michael R reported acquisition or exercise transactions in this Form 4 filing.
CAMDEN NATIONAL CORP EVP Michael R. Archer received an equity grant of 1,922 shares of common stock as a restricted stock award. The grant value is based on a price of $50.67 per share and is part of the company’s 2022 Equity and Incentive Plan and its amendment.
The restricted shares are scheduled to vest pro rata over the next three years, conditioned on his continued employment through each vesting date. After this grant, Archer directly holds a total of 21,339.073 shares of common stock, including 9,725 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Smyth Renee reported acquisition or exercise transactions in this Form 4 filing.
Camden National Corp executive Renee Smyth received a routine equity grant in company stock. She was awarded 1,174 shares of common stock on April 28, 2026 at a grant value of $50.67 per share under the 2022 Equity and Incentive Plan and its amendment.
The award consists of restricted stock scheduled to vest pro-rata over the next three years, subject to continued employment. After this grant, Smyth directly holds 29,538.604 shares of common stock, which includes 6,844 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.
Camden National Corp EVP Barbara Raths received an equity grant of 1,105 shares of common stock, reported as a restricted stock award under the company’s 2022 Equity and Incentive Plan and its amendment. The award is compensation, not an open-market purchase, and is scheduled to vest pro-rata over the next three years, subject to her continued employment through each vesting date.
Each restricted stock award converts into one share of common stock at vesting. Following this grant, she directly holds a total of 9,341 shares of Camden National common stock, including 6,051 restricted stock units and restricted shares that remain subject to vesting and forfeiture conditions.